CVS CFO Highlights Aetna Margin Progress and 2027 Cost Headwinds
CVS executives said momentum is improving across Aetna, pharmacy, and care delivery, while healthcare cost trends remain uncertain into 2027. CFO Brian Newman cited steady Aetna progress toward target margins, mid-single-digit pharmacy growth, and expected Caremark guidance. He noted 12 of Aetna’s 13 senior executives have joined in the past two years and that CostVantage supports margins on prescriptions, including GLP-1s.